Mikael Brönnegård
Direttore/Membro del Consiglio presso Biopart Venture AB
Profilo
Mikael Brönnegård is currently a Director at Biopart Venture AB and Gothia Förlag AB.
He was previously the CEO & Investor Relations Contact at Abliva AB from 2012 to 2015.
He also held positions as Chief Executive Officer at ISR Immune System Regulation Holding AB, Director at IdMos Plc from 2007 to 2007, and Director at Quiatech AB.
Brönnegård obtained a doctorate degree from Karolinska Institutet.
Posizioni attive di Mikael Brönnegård
| Società | Posizione | Inizio |
|---|---|---|
| Biopart Venture AB | Direttore/Membro del Consiglio | 01/01/2001 |
Gothia Förlag AB
 Gothia Förlag AB Commercial Printing/FormsCommercial Services Gothia Förlag AB is a publishing private company based in Stockholm, Sweden. The Swedish company provides publishing services. | Direttore/Membro del Consiglio | 01/01/2006 |
Precedenti posizioni note di Mikael Brönnegård
| Società | Posizione | Fine |
|---|---|---|
| ABLIVA AB | Amministratore Delegato | 01/09/2015 |
Quiatech AB
 Quiatech AB Pharmaceuticals: MajorHealth Technology Quiatech AB develops and manufactures drugs. It is a research based company that develops enabling technologies for genetic analysis, molecular diagnostics, and gene-based therapeutics in the expanding market of DNA technologies that offer significant improvements in the quality of DNA microarray and other DNA oligonucleotide data. It has also developed a new modified RNA chemistry (Qt RNA Technology) utilizing a novel 2 protecting group on the RNA amidites, this development greatly improves the synthesis conditions, producing fully functional RNA at high yields. It is headquartered in Uppsala, Sweden. | Direttore/Membro del Consiglio | 30/08/2007 |
IdMos Plc
 IdMos Plc Medical SpecialtiesHealth Technology IdMos Plc engages in research, development and commercialization of its disease detection and monitoring technology. The company is headquartered in Dundee, the United Kingdom. | Direttore/Membro del Consiglio | 01/01/2007 |
| ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL) | Amministratore Delegato | - |
Formazione di Mikael Brönnegård
| Karolinska Institutet | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ABLIVA AB | Health Technology |
| Aziende private | 5 |
|---|---|
IdMos Plc
IdMos Plc Medical SpecialtiesHealth Technology IdMos Plc engages in research, development and commercialization of its disease detection and monitoring technology. The company is headquartered in Dundee, the United Kingdom. | Health Technology |
Quiatech AB
Quiatech AB Pharmaceuticals: MajorHealth Technology Quiatech AB develops and manufactures drugs. It is a research based company that develops enabling technologies for genetic analysis, molecular diagnostics, and gene-based therapeutics in the expanding market of DNA technologies that offer significant improvements in the quality of DNA microarray and other DNA oligonucleotide data. It has also developed a new modified RNA chemistry (Qt RNA Technology) utilizing a novel 2 protecting group on the RNA amidites, this development greatly improves the synthesis conditions, producing fully functional RNA at high yields. It is headquartered in Uppsala, Sweden. | Health Technology |
| Biopart Venture AB | |
Gothia Förlag AB
Gothia Förlag AB Commercial Printing/FormsCommercial Services Gothia Förlag AB is a publishing private company based in Stockholm, Sweden. The Swedish company provides publishing services. | Commercial Services |
ISR Immune System Regulation Holding AB
 ISR Immune System Regulation Holding AB Pharmaceuticals: MajorHealth Technology ISR Immune System Regulation Holding AB engages in pharmaceutical research for the treatment of viral diseases focusing on Human Immunodeficiency Virus (HIV). It is developing ISR048 for the novel treatment of HIV. The company was founded by Yen Lundgren and Ulf Ljungblad in September 17, 2015 and is headquartered in Solna, Sweden. | Health Technology |
- Borsa valori
- Insiders
- Mikael Brönnegård
